Trial Identifier: | D781PC00001 |
Sponsor: | AstraZeneca |
Collaborator: |
Daiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, Tokyo
|
Start Date: | June 2024 |
Primary Completion Date: | April 2028 |
Study Completion Date: | March 2029 |
Condition: | Liver Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
AT | Linz, AT, 4010 |
AT | Salzburg, AT, 5020 |
AT | Wien, AT, 1090 |
AT | Wiener Neustadt, AT, 2700 |
BE | Anderlecht, BE, 1070 |
BE | Edegem, BE, 2650 |
BE | Leuven, BE, 3000 |
BE | Liège, BE, 4000 |
BE | Roeselare, BE, 8800 |
BR | Porto Alegre, BR, 90035-000 |
BR | Sao Paulo, BR, 01246-000 |
CA, NS | Halifax, NS, CA, B3H 1V7 |
CA, ON | Toronto, ON, CA, M5G 2M9 |
CA, QC | Montreal, QC, CA, H3A 1A1 |
DE | Berlin, DE, 13353 |
DE | Dresden, DE, 01370 |
DE | Frankfurt, DE, 60488 |
DE | Göttingen, DE, 37075 |
DE | Hamburg, DE, 22763 |
DE | Köln, DE, 50937 |
DE | Leipzig, DE, 4103 |
DE | Lübeck, DE, 23538 |
DE | Munchen, DE, 81377, DE |
DE | Ulm, DE, 89081 |
DE | Wuerzburg, DE, 97080 |
JP | Kashiwa, JP, 227-8577 |
JP | Koto-ku, JP, 135-8550 |
JP | Osaka-shi, JP, 541-8567 |
JP | Suita-city, JP, 565-0871 |
JP | Yokohama-shi, JP, 241-8515 |
KR | Seoul, KR, 03080 |
NL | ROTTERDAM, NL, 3015 GD |
TW | Kaohsiung, TW, 833 |
TW | Taipei, TW, 112 |
TW | Taipei, TW, 10002 |
TW | Taoyuan, TW, 333 |